Could shockwaves replace pills for overactive bladder?

NCT ID NCT07473310

Recruiting now Disease control Sponsor: Mansoura University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether low-intensity shockwave therapy can improve overactive bladder symptoms in women as well as or better than the standard drug solifenacin. Seventy women will be randomly assigned to receive either weekly shockwave sessions for 8 weeks or a daily pill for 12 months. Researchers will track symptom scores, urinary diaries, and quality of life to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-intensity shockwave therapy
What this could lead to: If successful, this could offer a non-drug, non-invasive option for women with overactive bladder, reducing symptoms without daily medication.
What could go wrong: This is a small Phase 4 trial with only 70 participants, so results may not apply to all women. Shockwave therapy is still experimental for this condition, and its long-term benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER (OAB) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

overactive bladder Urinary Incontinence, Urge

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERACTIVE BLADDER (OAB) URGE INCONTINENCE

Contacts and locations

Locations

Mansoura Faculty of medicine
RECRUITING

Al Mansurah, Dakahlia Governorate, 35111, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.